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ABSTRACT: This intervention before surgery has 
been termed prehabilitation. The one known cure to 
pancreatic cancer is surgery. The most common 
surgery for pancreatic cancer, 
pancreaticoduodenectomy, has the highest 
complication rate which is why the focus was on 
this type of surgery. Early nutrition education and 
exercise intervention prior to surgery has been 
looked at in other types of cancers , although it has 
yet to be studied in pancreatic cancer patients. This 
is part of a larger study looking at prehabilitation 
on quality of life. This specific study is the 
preliminary analysis looking at the effect of the 
intervention on weight, muscle mass, and dietary 
intake. 
This study looked at 24-Hour Recall and BIA 
analysis at baseline and 1 month post-surgery for 
individuals undergoing a 
pancreaticoduodenectomy. Results were also 
analyzed following post hoc group assignments 
based on baseline hand grip strength. Comparisons 
were made to determine if nutrition education 
during the prehabilitation phase was beneficial 
overall. This is a preliminary analysis for a larger 
study to help better assess if further stratification 
needs to occur for intervention. 
Keywords: prehabilitation, muscle mass, weight, 
dietary consumption, hand grip strength, pancreatic 
cancer patients 
 INTRODUCTION  
Pancreatic cancer accounts for 3.1% of all 
new cases of cancer in the Pakistan with an 
estimated 5307 new cases in 2016. The 5-year 
survival rate for pancreatic cancer is currently 
7.7%. Pancreatic cancer is not easily diagnosed, 
therefore many patients are not diagnosed until 
their cancer is very advanced. 
The pancreas is a major organ in the 
human body. This organ is located in the abdomen 
behind the stomach and attaches to the gall bladder 
and part of the intestine, which is referred to as the 
duodenum. The main duct of the pancreas attaches 
to the gallbladder by the common bile duct, and 
this is where bile mixes with the pancreatic 
enzymes before being released into the duodenum. 
The pancreas has many functions including 
producing and excreting enzymes and hormones 
such as insulin. Insulin is a hormone that helps the 
body absorb, use, and regulate glucose or blood 
sugar level. The enzymes produced and secreted by 
the pancreas are involved in breaking down the 
foods consumed and are often referred to as the 
digestive juices. These juices are mixed with the 
bile secreted by the gall bladder and deposited into 
the duodenum to aid in the digestion of food. If the 
pancreas is unable to produce and secrete these 
enzymes, the body is not able to properly digest 
food as well as not being able to regulate serum 
glucose. 
Early pancreatic cancer does not present 
with many symptoms. It is not until the cancer 
starts to advance and blocks the ducts that excrete 
enzymes that symptoms appear. Symptoms can 
include jaundice, dark urine, light-colored or 
greasy stools, itching, weight loss, poor appetite, 
nausea, vomiting, stomach pain, back pain, and 
even diabetes or uncontrolled blood sugar 
levels.[2] Diagnosing can be done using (a) 
physical exam checking for lumps or anything else 
unusual; (b) history looking at patient’s habits, past 
illnesses, and treatments; (c) blood chemical 
measurements looking at markers like bilirubin, 
tumor marker test where substances such as CA 
19-9 or carcinoembronic antigen can be detected to 
mark for cancer; (d) MRI which uses magnet, radio 
waves, and computer technology to take a picture 
of the inside of the body; (e) CT scan which is 
another way of taking images of the inside of the 
body, but is using a computer and x-ray machines; 
(f) PET scan which is used to find the malignant 
tumor cells in the body by injecting radioactive 
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glucose into the vein; (g) abdominal ultrasound, 
which is used to take images inside the abdomen 
by an ultrasound transducer being pressed against 
the skin and directing high energy sound waves 
into the abdomen; (h) an endoscopic ultrasound 
(EUS) which is when an endoscope (tube-like 
instrument with a light and lens on the end) is 
placed into the body through mouth or rectum and 
bounces high-energy sound waves off internal 
tissues to make echoes; (i) endoscopic retrograde 
cholangiopancreatography (ERCP) which uses x-
rays to image the ducts  that carry bile from the 
liver to the gallbladder and from gallbladder to 
small intestine (j) Percutaneous transhepatic 
cholangiography (PTC) which is used to x-ray the 
liver and bile ducts; (k) laparoscopy, which is a 
surgical procedure to look inside the body by 
making a small opening in the abdomen; (l) Biopsy 
which is a removal of cells or tissues so that they 
can be checked for the biochemical markers of 
cancer.[3] 
If the cancer is found in only the pancreas, 
it is usually referred to as localized, and if it has 
spread to other areas in the body, it is referred to as 
regional or distant (metastasized) versus a 
localized tumor. Specific staging used for 
pancreatic cancer are Stages 0, I, II, III, and IV. 
Stage 0 is referred to as carcinoma in situ; this  is 
when 
A PD is a radical surgery in which a 
major section of the gastrointestinal (GI) tract, 
including the head of the pancreas, gallbladder, 
duodenum, and a portion of the common bile duct, 
is removed. The surgeon then reconnects the 
remaining pancreas to the stomach, small intestine, 
and common bile duct so that the contents of the 
stomach combine with bile and pancreatic enzymes 
to pass through the duodenum. Because of the 
extent of this surgery there is a very high 
complication rate. Because of the commonality and 
complication rate, this study was specifically 
focused on patients who underwent a PD. 
Study Purpose and Specific Aims  
This specific preliminary analysis is 
investigating increasing protein intake prior to PD 
and its effect on food intake, especially protein 
intake, measured by a 24-hour recall, and body 
composition, muscle mass/fat free mass (FFM) and 
weight, measured by bioelectrical impedance 
analysis (BIA). Based on previous research we 
hypothesize that intervening nutritionally shortly 
after diagnosis for resectable pancreatic cancer 
would minimize risk of undernutrition along with 
the negative effects that usually coincide [35, 36]. I 
also wanted to determine if these outcomes change 
based on a participant’s HGS. Since HGS has been 
noted as a determinant for muscle function and 
nutritional status we could hypothesize that 
comparing groups based on HGS would indicate a 
change in outcomes following surgery. 
Hypothesis: Nutrition education during 
the prehabilitation phase will increase FFM and 
dietary protein intake and decrease weight loss 
when baseline data is compared to 1 month post-
surgery. 
Specific Aim 1: To compare the change 
in FFM 1 month post-surgery to baseline FFM by 
assessing BIA results between participants 
categorized as at/above average HGS and below 
average HGS. 
Specific Aim 2: To compare the change 
in body weight 1 month post-surgery to baseline 
weight between participants categorized as 
at/above average HGS and below average HGS. 
Specific Aim 3: To describe dietary 
intake for patients undergoing PD at baseline and 1 
month post-surgery. 
LITERATURE REVIEW 
Complications: 
Each PD is patient-specific regarding the 
amount of GI tract removed, and thus individuals 
vary regarding postoperative impairments in 
digestion and absorption.[8] This procedure does 
remove a large portion of the pancreas, but this 
does not mean that the patient will become a 
diabetic. Only about 4% of patients who undergo 
PD will get diabetes.[9] If the patient was not 
diabetic prior to surgery, it is not likely this will 
cause them to be diabetic. 
Other complications of a PD may include 
wound infection, bile leak, pancreatic fistula, intra-
abdominal abscess, abdominal hernia, delayed 
gastric emptying, fat  alabsorption, dumping 
syndrome, and difficulty tolerating a regular 
diet.[7, 10, 11] These complications may inhibit 
the patient’s return to an adequate nutritional 
status. 
A bile or pancreatic leak is caused when 
connection is not complete at the site of the 
pancreas, common bile duct, and duodenum 
anastomosis. This leak can cause other 
complications such as sepsis and abscesses. 
Incidence of these leaks varies based on reports 
and differences in surgical techniques. [13] 
Pancreatic fistula is a common 
complication following a bile or pancreatic leak. A 
fistula is an abnormal passage between two hollow 
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or tubular organs. A pancreatic fistula would be a 
fistula found in the pancreas with a passage to the 
jejunum or other surrounding organs. This can be 
surgically made or occur naturally at the internal 
incision site following the surgery. [14] 
An intra-abdominal abscess usually 
occurs secondary to a leak where the pancreas is 
reconnected either with the common bile duct or 
small intestine. This is a collection of fluid in the 
abdomen that may require drainage. The incidence 
of an intra-abdominal abscess ranges from 1%-
12%. This complication is easily controlled as long 
as the primary drainage or leak is resolved. [13] 
Delayed gastric emptying is another major 
complication following a PD. The incidence is up 
to about 45%.[13, 16] Delayed gastric emptying is 
the delay in the spontaneous movement of muscles 
in the stomach following surgery. It is common 
after any abdominal surgery for the stomach to 
take time to adjust before functioning normally 
again although after a PD the time the stomach 
takes is increased. Delayed gastric emptying is a 
major source of discomfort and causes the delay in 
tolerating a regular diet, but it typically resolves 
itself within about 4-6 weeks following surgery. 
This complication can interfere with the normal 
digestion of foods and the regulation of blood 
sugar levels and can cause nausea, vomiting, and 
early satiety. [13, 17] 
Fat malabsorption refers to the body’s 
inability to utilize fat from the diet. Without certain 
enzymes produced and excreted by the pancreas, 
the body is not able to digest and absorb dietary 
fats from foods, which leads to fat malabsorption. 
This is most often seen by changes in stools. Stools 
that are light in color, bulky, float, and are oily are 
often indicators of fat malabsorption. Other 
symptoms include bloating and excess gas with 
extreme foul odor.[18] Fat malabsorption 
following a PD is an indicator for supplementary 
pancreatic enzymes. Initial fat malabsorption after 
surgery may resolve on its own as the 
gastrointestinal tract resumes adequate function 
and delayed gastric emptying resolves.[13] 
Occasionally the pancreas, even after surgery, does 
not produce an adequate amount of enzymes to 
properly digest foods. Enzyme supplements are 
taken orally with foods to mimic the enzymes the 
pancreas is supposed to produce. 
Difficulty tolerating a regular diet is 
another complication specifically individualized 
for each patient. This tolerance issue may be 
related to any of the complications previously 
listed. The degree each complication can inhibit 
intake is dependent on how the patient feels. 
Delayed gastric emptying is one of the bigger 
complications effecting dietary tolerance. Early 
satiety, nausea, and vomiting can all decrease the 
person’s desire to eat. Fat malabsorption may also 
cause difficulty with tolerating a regular diet 
because the person may feel they are not properly 
digesting their foods or they may feel bloated and 
gaseous after eating specific foods causing them to 
limit certain foods. Fat malabsorption can be a 
cause to inadequate dietary intake if they are not 
reporting these symptoms to their physicians in 
order to get the needed enzymes to supplement. 
Prehabilitation: 
Previous studies on other cancers have 
shown the benefit of initial nutrition counseling 
and early exercise interventions on quality of life 
(QOL). This initial intervention has been termed 
prehabilitation.[35-38] 
Weight loss is an acknowledged issue in 
cancer patients and is known to worsen 
prognosis.[39, 40] Ravasco et al.[36] discusses that 
the treatment provided is not the only thing that 
affects the patient’s QOL, but nutritional status and 
intake also play a large role. Previously, Ravasco 
et al. had seen that weight loss related to cancer 
will decrease QOL, tolerance to further treatments, 
and prognosis.[39-42] The high prevalence of 
malnutrition in cancer patients was also a concern. 
Ravasco et al. noted that there was a high 
correlation between worsening nutrition status 
depending on cancer staging, location, duration of 
disease, previous surgery or neoadjuvant therapy, 
along with protein energy intake.[43] Ravasco et 
al. measured QOL outcomes since it is able to 
measure the self-reported change in functional, 
physical, and psychological health along with the 
person’s experiences , beliefs, expectations, and 
perceptions of human and financial costs to 
determine the effect of nutrition interventions on 
QOL in cancer patients. 
Ravasco et al. specifically looked at 271 
individuals with cancer of the head and neck, 
esophagus, stomach, and colon/rectum undergoing 
radiation therapy. This study ran for 3 months 
following radiation therapy and consisted of three 
randomized nutritional arms as follows: 1. 
individualized nutritional counseling, 2. ad libitum 
diet plus high protein supplements , and 3. ad 
libitum diet. Nutrition education was based on 
regular foods and prescribed based on dietary 
guidelines provided both orally and written. 
Individuals were provided a dietary plan that 
included a meal plan in quantity, type of foods, and 
meal distribution which was based on their 
individualized location of cancer, treatment they 
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were undergoing, symptoms, nutritional status, and 
previous changes in weight. 
Ravasco et al. did show that the 
individualized nutrition counseling was shown to 
improve outcomes on those inpatients who 
reported lowest QOL scores and nutritional 
problems during radiation therapy. The results 
were separated based on the type of cancer 
presented (esophagus, stomach, colorectal, head-
neck, and the lower risk cancers such as breast, 
prostate, uterus, brain). QOL scores were improved 
or remained constant throughout the study for all 
cancers for the global QOL functional scale, 
physical function, role function, cognitive function, 
and social function, and emotional function. As for 
symptoms, fatigue appeared to worsen in the 
esophageal group, but all other cancers showed a 
decrease. Nausea, vomiting, and pain all appeared 
to not improve following intervention. Dyspnea, 
sleep disturbance, constipation, and finance 
appeared to be stable throughout intervention. 
Appetite only improved in the head-neck cancer 
patients and remained stable for both colorectal 
and low-risk cancers. For this study, dietary 
counseling was shown to improve overall QOL, 
specifically function, significantly, even with the 
medium individual symptoms not improving. 
MATERIALS AND METHODS  
Subjects: 
A total of 20 participants aged > 30 years 
were enrolled between March 2016 and January 
2017 at the Shaukat Khanum Memorial Cancer 
Hospital and Research Centre, Lahore Participants 
were newly diagnosed with pancreatic or related 
cancers who were deemed eligible for a PD and 
appropriate for exercise by the pancreatic cancer 
team. Participants can be newly diagnosed or 
following chemotherapy. Data collection occurred 
between March 2016 and March 2017. 
This preliminary study is a subset of a 
much larger study titled: “Preoperative Exercise 
and Nutrition to Improve Pancreatic Cancer 
Outcomes by Targeting Sarcopenia: A 
Translational Pilot RCT” that is on-going at the 
Shaukat Khanum Memorial Cancer Hospital 
and Research Centre . This study is investigating 
increasing protein intake and physical activity prior 
to PD and its effect on pancreatic cancer outcomes. 
For this study, the purpose is to look at the impact 
of 2-3 weeks of protein supplementation and 
exercise, with or without targeted strengthening, in 
order to determine if targeted strengthening 
improves outcomes post-surgery. The specific aims 
are to: 1. quantify the impact of muscle 
strengthening on post-op outcomes, 2. determine 
whether novel serum and tumor biomarkers of 
cachexia and sarcopenia explain the impact of 
targeted strengthening, and 3. determine if pre-op 
biomarkers or physical function tests predict post-
op outcomes. This study is looking at individuals 
30 years of age or older with either pancreatic 
cancer or related pre-malignant conditions who are 
randomized to pre-operatively protein plus either 
aerobic exercise alone or aerobic exercise plus 
strengthening exercises. This larger study also 
allows subjects to participate as “assessment only” 
if they meet criteria which means they do not want 
to do the specific interventions, but are willing to 
do all baseline testing. Inclusion criteria include: 
(a) pancreatic cancer and related malignancies or 
pre-malignant and tentatively approved for surgical 
resection; (b) cognition and English language skills 
sufficient for consent and questionnaires; (c) age > 
30 years; (d) Able to rise from a chair and walk 
household distances; (e) willing to be randomized 
to pre-operative home-based exercise and protein; 
(f) cleared for exercise participation by the 
pancreatic cancer team. 
For this study, 4 assessments will be performed, 
and are generally on the same days as scheduled 
with their surgeon at the Stephenson Cancer 
Center. Visit 1 will occur around time of the 
pancreatic cancer surgical candidacy and is where 
eligibility will be determined and baseline testing 
will be done. Visit 2 is pre-operative, 
approximately 1-3 days prior to surgery and 
approximately 2-3 weeks following visit one. The 
third visit is post-operative and is the first post-
operative visit to the pancreas clinic meeting with 
the surgeon, approximately 1 month post-surgery 
or 2 weeks post discharge from the hospital. The 
fourth and final visit is approximately 3-4 months 
post-surgery and will coincide with follow-up visit 
with the surgeon at the Stephenson Cancer Center. 
The study will be blinded, meaning the 
individuals in the study who know the group 
assignment will not collect any data on outcomes, 
and participants will only know the arm of the 
study they are assigned to and not the difference 
between the two arms or the specific aspects of the 
protocol. The intervention materials provided, 
protein supplements, and exercise equipment are 
provided to the participants at no charge to them. 
The primary outcome for this larger study 
is to look at: (a) performance as walking endurance 
and muscle strength; (b) body composition by BMI 
and bioimpedance; (c) post-op hospital length of 
stay, complications, readmissions . The larger study 
was powered based on QOL, specifically FACT-G. 
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Participants are identified in 
Gastrointestinal Tumor Board that occurs weekly 
on Wednesdays at the Shaukat Khanum Memorial 
Cancer Hospital and Research Centre. In 
Gastrointestinal Tumor Board, is an 
interdisciplinary team meets to determine surgical 
candidacy of patients based on MRI and PET scans 
along with blood and tissue samples. Participants 
are identified to be a part of this study based on 
inclusion listed below. Participants must be 
eligible for the PD surgery. 
Hand Grip Strength 
HGS is a useful tool to measure 
nutritional status. Malnutrition has been found to 
be an independent determinant for HGS[30]. HGS 
can be completed on patients independent of 
physical ability and is a relevant marker of 
functional status. To measure HGS, this study used 
a JAMAR Hydraulic hand dynamometer[44]. 
JAMAR 5-position pre-set grip position #2 for all 
participants were used. Measurements were 
obtained with participants sitting upright in a chair 
with their shoulder adducted and neutrally rotated, 
elbow flexed at a 90-degree angle, and wrist in a 
neutral position. The participant’s wrist is in 
neutral radial/ulnar deviation and neutral to slight 
extension for comfortable gripping position. The 
physical therapist supported the bottom of the 
dynamometer for the participant so that the 
participant does not need to support the weight of 
the device while squeezing. Participants were 
asked to contract their hand with maximum 
strength, and verbal encouragement was  provided. 
Each participant was instructed to perform 3 
measures with a 30-second break between 
measurements; participants were also instructed 
when to start and stop contractions. Measurements 
using the dominant hand from each trial were 
averaged and used at baseline to determine post 
hoc group assignment. 
For this preliminary analysis, participants 
were separated into groups based on comparison of 
their HGS as either at or above average HGS and 
below average HGS. Classification of average or 
below average is determined based on age and sex. 
 
Table 1.0-Normative hand grip values in kilograms, from Lafayette Jamar Hand Dynamometer user manual 
2003 
AGE R-HANDED L-HANDED R-HANDED L-HANDED MALES MALES FEMALES FEMALES 
30-34 55.4 50.2 35.8 30.9 
     
35-39 54.4 51.3 33.7 30.1 
     
40-44 53.1 51.3 32.0 28.3 
     
45-49 49.9 45.8 28.3 25.5 
     
50-54 51.6 46.3 29.9 26.0 
     
55-59 45.9 37.8 26.0 21.5 
     
60-64 40.8 34.9 25.0 20.8 
     
65-69 41.4 34.9 22.5 18.6 
     
70-74 34.2 29.5 22.5 18.9 
     
75+ 29.8 25.0 19.4 17.1 
     
JAMAR Hydraulic Hand Dynamometer 
 
24-Hour Recall 
Food intake was measured by a 24-hour recall. A 
24-hour recall is a structured interview focused on 
dietary intake within a previous 24-hour period, 
including all foods/beverages consumed.[45] For 
this study, a 24-hour recall was performed both at 
the initial visit and at 1 month following surgery. 
The 24-Hour Recalls were performed by a 
Registered Dietitian (RD). During this interview, 
the participants were instructed to provide all foods 
and beverages consumed the previous day, 
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including amount consumed and all ingredients, if 
possible. The RD is instructed to begin with a 
quick list of foods eaten as the participant 
remembers starting as the first thing consumed 
when they first woke up. Then the RD will 
question further into any forgotten foods, 
ingredients when made at home, restaurants if not 
mentioned previously, servings size, and amount 
eaten. 
The 24-hour recalls were analyzed by 
FoodWorks version 15 software. Total calories, 
carbohydrates, protein, and fat were observed at 
both visits as descriptive statistics only. Total 
amount of protein recorded for the baseline 24-
hour recall was totaled and used to measure protein 
supplementation needs during the intervention 
period. 
BIA Analysis  
BIA is used to measure the outcome 
change in weight and FFM for the purposes of this 
study. BIA is a non-invasive tool that is widely 
used for measuring body composition. This tool 
uses small alternating currents to measure weight, 
BMI, basal metabolic rate (BMR), total body water 
(TBW), fat mass (FM), and FFM.[46-48] BIA is a 
measurement which can be performed on 
participants unless the participant has a pacemaker, 
any other internal electronic devices, or cannot 
stand unassisted for 1 minute. 
For this study, we used the Tanita TBF-
310GS Total Body Composition Analyzer which is 
similar in appearance to a household scale. Needed 
information including height, age, gender, physical 
activity (equal to/greater than or less than 10 hours 
or more of intense exercise per week) was stated 
by the participant and input into the device for 
analysis. Participants were then asked to remove 
shoes and socks, leaving nylons on if necessary, 
and stand on the scale ensuring part of their feet 
where touching all four of the electrodes. 
Participants were instructed to stand still without 
holding on to anything for support and were 
instructed when to step off. Results from both 
visits were documented for final analysis. 
Education & Supplementation 
The nutrition education was created 
specifically for this project and included a handout 
along with verbal instructions on the importance of 
protein, foods high in protein, different ways to 
add protein to the diet, how to read a food label, 
and how to appropriately use nutritional 
supplements. These individual sessions are 
provided by the RD and last approximately 15 
minutes. 
Protein needs were based on a range of 
1.3-1.5 grams per kilogram of body weight at time 
of visit (adjusted body weight if BMI >40).[49, 50] 
Baseline 24-hour recall was compared to the 
calculated range of protein needs. If current intake 
fell short of estimated needs, participants were 
instructed on supplementing protein with whey 
protein powder (Beneprotein ) as needed starting 
the day after education until 5 days prior to 
surgery.[51] Starting 5 days prior to surgery, all 
participants were instructed to change from the 
whey protein powder to an immune-enhancing 
protocol (Impact AR ). Impact AR is a nutritional 
supplement that has been shown to boost immune 
function while still providing 18g protein in each 
container.[52] This nutritional supplement is part 
of the standard of care in the pancreas clinic of the 
Stephenson Cancer Center as well is often 
provided post-surgery prior to discharge. 
Physical therapy intervention was also 
included for each participant as part of the larger 
trial. Participants were randomized to either 
aerobic exercises or aerobic exercises plus 
strengthening: A seated aerobic intervention, 
stretching, and exercises for all 4 limbs to be 
performed either as active motion, or with weights 
as personalized strengthening intervention. Group 
1 (aerobic group) is considered the standard care 
for individuals referred to physical therapy prior to 
surgery. This group met with a physical therapist 
where they were provided with a standardized 
home-based exercise plan. This included 
instructions on lower body stretching and active 
range of motion, and a portable upper/lower body 
ergometer and encouraged to achieve a target of 60 
minutes of daily exercise. Individuals are 
instructed to spread out exercise as needed related 
to heart rate, and/or symptoms to self-monitoring 
response as noted on the Borg Rate of Perceived 
Exertion (RPE) scale. 
Group 2 (aerobic plus strength) 
received the same aerobic 
instructions as group 
This group received further counseling on 
individualized moderate intensity strength training. 
The amount of resistance is determined following 
baseline testing and individualized to participant 
needs. Group 2 received not only the portable body 
ergometer, but also weights to serve as the 
resistance and instructions on how to increase 
resistance. 
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Figure 1.0-Participant time table 
 
Gastrointestinal Tumor Board 
 Determined if candidate for study 
 
↓ 
 
Baseline seen in Pancreas Clinic 
• Deemed eligible for surgery 
 
 
↓ 
 
Baseline testing 
• Data collection: 
• Hand Grip Strength 
• 24-hour recall 
• BIA 
 
↓ 
 
Surgery 
↓ 
 
1 month post-surgery 
 
 Data collection: 
 24-hour recall obtained, 
  BIA Analysis 
 
Exercise intervention is not noted in 
outcomes for this study. Since exercises are part of 
the larger study, they are important to note since 
exercise intervention assessment may alter results. 
Second Visit/1-month post-op: 
The second visit assessed for this study 
occurred approximately 1 month following 
surgery. This date will vary based on when the 
participant is discharged from the hospital, but will 
be scheduled two weeks following discharge. Data 
collection for this visit includes BIA and 24-hour 
recall. 
Statistical Analysis  
For this preliminary analysis, 
participants were compared at baseline and 1 
month post-surgery. Data collection occurred 
March 2016-March 2017. A statistician working 
specifically with this preliminary analysis aided 
in assessing the computed results. The specific 
aims were measured using a repeated measures 
ANOVA analysis of variance but power was 
anticipated to be inadequate due to the small 
sample size. Repeated measures ANOVA is 
known as an analysis of dependencies and is to 
prove cause-effect relationship between the 
independent variables by measuring the equality 
of means. All members of the sample were 
measured under a number of different conditions, 
therefore the testing of the means by repeated 
measures ANOVA was appropriate. Independent 
variables were Statistical significance was set at 
p <0.05. 
Descriptive statistics were computed 
for weight, in pounds %FFM, FFM in pounds, 
% calories from protein, % calories from fat, % 
calories from carbohydrates between baseline 
and 1 month post-surgery compared between 
groups (average and below average HGS). All 
statistical tests were performed using a 5% 
chance of a type 1 error. 
Aim 1: Change in FFM (%FFM and FFM in 
pounds) between baseline and 1 month post-
surgery was compared between groups 
(average and below average HGS) by repeated 
measures ANOVA. 
Aim 2: Change in weight (in pounds) between 
baseline and 1 month post-surgery was 
compared between groups (average and below 
average HGS) by repeated measures ANOVA. 
Aim 3: Mean intake (% calories from protein, 
fat, and carbohydrates) was compared between 
groups (average and below average HGS) at 
both time points using a repeated measure 
ANOVA 
RESULTS 
Participants: 
A total of 20 participants were collected 
for this preliminary analysis. These were the first 
20 participants of the larger study to complete 
HGS, 24-hour recall, and BIA analysis at baseline, 
and 24-hour recall and BIA analysis at one month 
post-surgery. Participants were excluded if they 
had incomplete or inaccurate data. Of these 
participants, 6 were above average HGS and 14 
were below average HGS. As far as randomization 
into the exercise groups, there were 4 at or above 
average HGS randomized to aerobic plus 
strengthening and 2 participants were randomized 
into aerobic only exercise. Of the below average 
HGS participants 7 were randomized into aerobic 
plus strengthening exercise and 7 randomized into 
aerobic only exercise. The larger trial’s inclusion 
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criteria allowed participants to be enrolled either 
immediately into surgery following diagnosis  (PP) 
or into surgery following neoadjuvant therapy 
(PC). Out of overall participants, 16 were PP while 
only 4 were PC. Of the at or above average HGS 
all participants were PP, which could indicate the 
possibility that neoadjuvant therapy has some 
effect on HGS. Of the below average HGS, 10 
were PP and 4 were PC. 
For 3 patients, data from visit 4 was used 
instead of visit 3. Visit 4 data was collected at 
their second follow-up visit with the surgeon at 
the Stephenson Cancer Center which was 
approximately 3 months following surgery. These 
original visits were excluded because either the 
visit was missed or data collection was 
incomplete. Results were still calculated based on 
these substitutions because of the closeness of 
visits and the small sample size. Two participants 
did not complete BIA at the 1 month post-surgery 
visit but were able to attain BIA at the 4th visit for 
the larger study. One participant was unable to 
complete 24-hour recall at the one month post-
surgery visit because visit was scheduled at time 
where no RD was available, so 24-hour recall was 
used from the 4
th
 visit. 
 
Table 2.0-Average participant data at baseline 
 
 At/Above Average Below Avera g e Overall 
 HGS HGS  
Average BMI kg/m
2
 kg/m
2
 26.5kg/m
2
 
    
Average HGS Total 32.8kg 25.0kg 23.7kg 
Average HGS Male 51.7kg 29.3kg 33.8kg 
Average HGS Female 23.3kg 19.2kg 20.8kg 
    
Male:Female 2:4 8:6 10:10 
Age 58.1y 67.9y 67.6y 
    
Aerobic:Aerobic + 2:4 7:7 9:11 
Strength    
PP:PC 6:0 10:4 16:4 
 
 
Aim 1: FFM 
Mean FFM in pounds at baseline for at or 
above average HGS and below average HGS were 
116.00 + 28.15 pounds and 117.43 + 27.09 pounds, 
respectively. Mean FFM in pounds at 1 month 
post-surgery for at or above average HGS and 
below average HGS were 112.92 + 28.62 pounds 
and 113.25 + 24.22 pounds, respectively. There 
was no noted difference in the change in FFM in 
pounds when comparing at/above average HGS 
participants to below average HGS (p=0.8414). 
When looking at the participants as a whole, there 
was no difference in the change in FFM in pounds 
from baseline to 1 month post-surgery (p=0.1266). 
Mean %FFM at baseline for at or above 
average HGS and below average HGS were 70.67 
+ 5.59% and 71.67 + 9.93%, respectively. Mean 
%FFM at one month post-surgery for at or above 
average HGS and below average HGS were 71.87 
+ 4.04% and 76.19 + 7.94%, respectively. There is 
no statistical difference when comparing the at or 
above average HGS to the below average HGS 
from baseline to 1 month post-surgery (p=0.3347). 
Both groups showed a 3.5% increase in %FFM 
from baseline to 1 month post-surgery (95% CI: 
0.3%, 6.7%; p=0.0328). 
 
Aim 2: Weight 
Results show that there is no difference in 
change of weight when comparing at or above 
average HGS to below average HGS (p=0.5133). 
Both groups shows a mean of 13.7 pounds lost 
from baseline to 1 month post-surgery (95% CI: 
10.1, 17.4; p<0.0001). 
Aim 3: Intake 
Dietary intake remains low following 
surgery; this has not changed since previous 
research. When comparing the change in foods 
between at or above average HGS and those who 
are below average HGS, there was no significant 
change from baseline to 1 month post-surgery 
between groups. 
 
Mean %calories from protein at baseline 
between at or above average HGS and those below 
average HGS were 15.37 + 4.87% and 20.21 + 
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8.18%, respectively. Mean %calories from protein 
at 1 month post-surgery between at or above 
average HGS and those below average HGS were 
18.10 + 3.04% and 16.86 + 6.19%, respectively. 
The change in %calories from protein was not 
different among the two groups (p=0.1740). There 
was also no change in %calories from protein, 
regardless of group, from baseline to 1 month post-
surgery (p=0.4588). 
 
Mean %calories from fat at baseline 
between at or above average HGS and those below 
average HGS were 41.68 + 10.52% and 35.01 + 
10.98%, respectively. Mean %calories from protein 
at 1 month post-surgery between at or above 
average HGS and those below average HGS were 
39.90 + 5.39% and 33.84 + 8.54%, respectively. 
There was no difference in the change in %calories 
from fat among both HGS groups from baseline to 
1 month post-surgery. (p=0.9233) Regardless of 
groups, there was no change in the %calories from 
fat from baseline to 1 month post-surgery 
(p=0.6389). 
 
Mean %calories from carbohydrates at 
baseline between at or above average HGS and 
those below average HGS were 42.97 + 14.38% 
and 44.79 + 10.62%, respectively. Mean %calories 
from carbohydrates at 1 month post-surgery 
between at or above average HGS and those below 
average HGS were 41.97 + 7.07% and 49.33 + 
9.12%, respectively. There was no difference in 
change in %calories from carbohydrates among 
both HGS groups from baseline to 1 month post-
surgery (p=0.4039). Regardless of group, there was 
no significant difference in change from baseline to 
1 month post-surgery (p=0.3412). 
Table 3.0-Descriptive statistics among hand grip strength groups for both baseline and 
one month post-surgery follow up time points  
 
 N Mean Std Dev Median Minimu Maximum 
     m  
FFM in Pounds       
       
At or Above Average HGS- 6 116.00 28.15 103.75 91.00 153.00 
Baseline/1-month post-surgery 6 112.92 28.62 108.75 81.50 147.00 
       
Below Average HGS-Baseline/ 14 117.43 27.09 121.75 63.00 168.50 
1-month post-surgery 14 113.25 24.22 111.25 82.50 172.00 
       
%FFM       
At or Above Average HGS- 6 70.67 5.59 69.49 64.12 79.07 
Baseline/1-month post-surgery 6 71.87 4.04 72.35 65.38 76.17 
       
Below Average HGS-Baseline/ 14 71.67 9.93 73.12 53.87 85.40 
1-month post-surgery 14 76.19 7.94 76.26 54.16 85.06 
Weight       
       
At or Above Average HGS- 6 164.33 38.35 157.00 126.50 224.00 
Baseline/1-month post-surgery 6 152.42 35.93 153.75 107.00 204.00 
       
Below Average HGS-Baseline/ 14 164.43 35.47 159.25 109.50 231.50 
1-month post-surgery 14 149.93 34.16 145.25 104.00 226.50 
       
%Calories from Protein       
At or Above Average HGS- 6 15.37 4.82 15.90 7.20 21.90 
Baseline/1-month post-surgery 6 18.10 3.04 17.05 15.70 23.80 
       
Below Average HGS-Baseline/ 14 20.21 8.18 18.15 11.20 43.30 
1-month post-surgery 14 16.86 6.19 16.50 8.60 31.30 
%Calories from Fat       
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At or Above Average HGS- 6 41.68 10.52 44.20 22.20 51.20 
Baseline/1-month post-surgery 6 39.90 5.39 39.75 32.90 47.20 
       
Below Average HGS-Baseline/ 14 35.01 10.98 36.45 16.80 52.40 
1-month post-surgery 14 33.84 8.54 31.55 23.20 54.40 
       
%Calories from Carbohydrates       
       
At or Above Average HGS- 6 42.97 14.38 40.05 30.30 70.60 
Baseline/1-month post-surgery 6 41.97 7.07 42.15 31.80 49.90 
       
Below Average HGS-Baseline/ 14 44.79 10.62 42.35 27.60 66.90 
1-month post-surgery 14 49.33 9.12 51.55 34.00 60.40 
       
 
Figure 2.0-Fat free mass (in pounds) among HGS groups from baseline to 1 month post- surgery 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.0-Percent FFM among HGS groups from baseline to 1 month post-surgery 
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Figure 4.0-Weight (in pounds) among HGS groups from baseline to 1 month post- surgery 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.0-Percent calories from protein among HGS groups from baseline to 1 month 
 
post-surgery 
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Figure 6.0-Percent calories from fat among HGS groups from baseline to 1 month post- 
 
surgery 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.0-Percent calories from carbohydrates among HGS groups from baseline to 1  
month post-surgery 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
Individuals were classified as either at or above 
average HGS or below average HGS at baseline. 
HGS has been previously used as a marker for 
malnutrition. Average HGS was used based on 
normative values for a population without any 
present disease markers. To my knowledge, set 
values for average HGS has not been determined 
for the cancer population at this time. 
Out of the 20 participants chosen, 11 individuals 
were randomized into aerobic plus strengthening 
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and 9 into aerobic only. Among the individuals 
classified as below average HGS, the individuals 
were equally distributed; 7 individuals in aerobic 
only and 7 individuals aerobic plus strengthening. 
Among individuals classified as at or above 
average HGS 4 individuals were aerobic plus 
strengthening and 2 were aerobic only. The 
exercise intervention may play a role in results, if 
strengthening causes more of an increase in FFM 
versus aerobic only intervention. The below 
average HGS group appeared to be equal in their 
intervention randomization, although the at or 
above average HGS participants were slightly 
skewed with 4 in aerobic plus strengthening and 2 
in aerobic only, therefore it is difficult to 
determine if the difference in exercise 
intervention played a role in FFM change. 
Weight loss, FFM loss, and decrease in dietary 
intake continue to occur post-PD despite 
education during the preoperative period. Figure 
2.0 shows the change in FFM in pounds between 
the two groups from baseline to 1 month post-
surgery. The below average HGS participants 
appear to have slightly more FFM in pounds at 
baseline than the at or above average HGS 
participants. At 1 month post-surgery, both groups 
appearto have the same FFM in pounds. However, 
these results were not statistically significant 
between groups or overall (p=0.8414 and 
p=0.1266, respectively). By looking at the lack of 
statistical differences there is no indication at this 
time that these individuals benefit from 
individualized interventions based on HGS. The 
below average HGS participants also showed a 
slightly bigger increase in pounds FFM. This 
could indicate the below average HGS 
participants may benefit more from the nutrition 
and exercise interventions. This could also 
indicate that no matter the classification of HGS, 
participants who undergo the prehabilitation 
program lose FFM at about the same rate. These 
results were regardless of exercise, with both 
HGS groups appearing equal in exercise 
randomization and assuming all exercises were 
completed as instructed. Although with such a 
small sample size this is difficult to determine. 
 
Figure 3.0 shows the change in %FFM among 
participants at or above average HGS and those 
below average HGS from baseline to 1 month post-
surgery. No statistically significant change was 
shown between groups with such a small sample 
size (p=0.3347). Both groups did have a 3.5% 
increase in %FFM from baseline to 1 month post-
surgery (p=0.0328). Looking individually at the at 
or above average HGS participants, they appear to 
be steady from baseline to 1 month post-surgery 
which could mean they may benefit from an 
increase in intervention during the preoperative 
period. This could also indicate that the below 
average HGS participants benefitted more from the 
prehab intervention since it appears they gained 
more %FFM from baseline to 1 month post-
surgery. Though, with such a small sample size, the 
difference between the groups is not yet clinically 
or statistically significant therefore no 
recommendations can be made. 
 
Figures 5.0-7.0 show the change in %calories from 
protein, fat, and carbohydrates for both groups 
between baseline and one month post-surgery. The 
below average HGS group appears to consume 
more of their calories from protein and 
carbohydrates than fat at baseline than the at or 
above average HGS group. At or above average 
HGS participants appear to have slight increase in 
%calories from protein at 1 month post-surgery. 
Both groups seem to have stable intake of fats 
from baseline to one month post-surgery. Below 
average HGS participants appear to intake less 
%calories from fat throughout both time periods. 
Below average HGS participants appear to 
increase %calories from carbohydrates slightly 
from baseline to 1 month post-surgery. Based on 
data presented I could conclude that the increase in 
%calories from carbohydrates may be related to 
the decrease in %calories from protein. Although, 
my clinical judgment leads me to believe that the 
increase in calories from carbohydrates are more 
likely related to tolerance issues. Especially if the 
participants were struggling with fat malabsorption 
or delayed gastric emptying the participants may 
be able to tolerate the foods higher in 
carbohydrates versus those that were higher in fat 
or protein. 
 
Figures 2.0-7.0 shows that there may be some 
slight indications of change in slope between 
groups at each time point and although not yet 
statistically significant this does have some 
clinical significance. Even with this preliminary 
analysis, there were some differences among 
groups classified as at or above average HGS 
versus those below average HGS. 
 
One month post-surgery results for all data may be 
inaccurate related to the participant data included 
for visit 4. With small sample size visit 4 was 
included for 3 participants who were not able to 
complete data for 1 month post-surgery. All three 
of these individuals were below average in HGS, 
therefore the 1 month post-surgery results for 
below average HGS may be slightly positively 
skewed. History shows that the increase in time 
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following surgery the lessening of the symptoms. 
This does not mean that functional or nutritional 
status are improving, but could show differences 
in results related to recovery time. 
 
Potential Implications  
If these results are indicative of the whole sample 
rather than separating based on HGS, then we 
could stipulate that based on this preliminary, 
underpowered analysis prehabilitation may be 
beneficial and the study should be continued to 
accrue to determine if these results hold true in the 
larger sample. Even though participants are 
continuing to lose weight, it appears that more 
weight is being lost from fat instead of FFM. If in 
fact participants are retaining their FFM then this 
could improve recovery time following surgery; 
therefore, participants would reach their pre-
surgery FFM quicker than without the 
prehabilitation intervention. If participants are able 
to improve their FFM mass more quickly, then 
they may improve post-surgery outcomes. 
 
Participants, and pancreatic cancer patients in 
general, often undergo to adjuvant therapy 
(chemotherapy, radiation therapy, chemoradiation 
therapy) following surgery. Following a PD 
patients are often malnourished and then go into 
adjuvant therapy; the side effects of adjuvant 
therapy often lead to a further nutritional decline 
and worsening symptoms. As seen in previous 
literature sarcopenia, or this further nutritional 
decline can worsen prognosis [5, 23]. 
Future Investigations  
This preliminary analysis is part of a much 
larger trial that is ongoing at the Stephenson 
Cancer Center. The study hopes to gain further 
site locations to increase the rate at which 
participants are enrolled. 
Based on the information gained from this study 
we can cautiously suggest there is a preliminary 
benefit of this early intervention during the 
prehabilitation phase such as increase in %calories 
from protein and %FFM mass. 
Further analysis is needed to better assess change 
in body composition. The larger trial is gaining a 
new tool to assess body composition in terms of 
specific body compartments. This new tool will 
compare body fat and FFM in each part of your 
body instead of telling total body composition 
changes. This tool allows for better assessment of 
compartmental body measures to assess adequacy 
of exercise interventions since. Change in muscle 
mass could also be compared based on observing 
CT scans since all participants receive this at 
baseline and typically post-surgery as well. 
Definitive conclusions cannot be made based on 
this preliminary analysis. Slight differences did 
appear through this preliminary analysis, with such 
a small sample size, although statistical 
significance was not achieved within this study, 
clinical significance is evident. Even without 
change in FFM in pounds, its results do indicate an 
increase in %FFM from baseline to 1 month post-
surgery. This could indicate that the exercise 
intervention plus increase in protein intake are 
appropriate to build muscle within the 2 weeks 
prior to PD. 
Nutrition education does cause a slight increase 
in %calories from protein from baseline to 1 
month post-surgery, and that indicates 
continued education may be beneficial clinically 
even without statistical significance. Further 
investigation is warranted. From this 
preliminary analysis, we can determine that 
there are small differences in these two HGS 
groups that may require separate individualized 
interventions although further analysis in a 
larger sample size is needed to determine true 
results. 
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